To minimize the occurrence of life-threatening complications associated with liposuction and fat grafting, the following actions are recommended
In 2026, more clinics are pairing peptide protocols with digital monitoring tools, whether thats wearables, continuous glucose monitoring, or symptom survey apps
10.22074/cellj.2016.4724 112
Factors that influence the decision include: baseline IGF-1 (lower IGF-1 may favor sermorelin to start), metabolic syndrome status (favors tesamorelin), visceral adiposity (favors tesamorelin), prior response to growth hormone-releasing peptides (helps calibrate dose), and patient tolerance preferences
Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
As with any investigational compound, results vary among individuals